Herpes simplex Virus – HSV Assay Kits
ELISA-VIDITEST and IF-VIDITEST anti-HSV1+2 Kits
Features
- Simultaneous detection of anti-HSV1 and anti-HSV2 antibodies
- Qualitative ELISA for IgG screening and quantitative version for determination of antibody concentration
- ELISA-VIDITEST anti-HSV1+2 IgM contains RF-sorbent for elimination of interfering IgG antibodies
- IF assays available for confirmation of the results
- High sensitivity/specificity verified in diagnostic evaluation study
Description
- ELISA-VIDITEST and IF-VIDITEST anti-HSV1+2 kits are intended for in vitro diagnosis of HSV type 1 or 2 associated diseases, i.e. herpes labialis, herpes genitalis, herpesvirus gingivostomatitis,
keratoconjunctivitis and herpesvirus-induced neurological complications (encephalitis, meningitis, inflammatory mono- and polyneuropathies). The diagnostic kit can also be utilized for differential diagnosis of neuroinfections,
infections of eye and skin and exanthematous diseases. The test does not distinguish between HSV1 and HSV2.
- Primary infections with herpes simplex virus type 1 or 2 are usually asymptomatic, or they reveal as non-specific symptoms such as pharyngitis, specific gingivostomatitis, and oral or genital cutaneous and mucosal lesions.
After primo infection the virus persists in organism in a latent state and may be reactivated at any time, usually after some kind of a triggering event. Reactivation of the latent virus is associated with appearance of
herpetic lesions at the site of virus entry.
- An infant being delivered through a birth canal carrying active lesions may develop a serious infection involving the central nervous system (herpetic encephalitis or meningitis), the mouth, eyes (keratoconjuctivitis),
or skin (generalized skin rash). The virus may cause severe complications in patients suffering from either inherited or acquired immune deficiency. Infection with HSV (especially with HSV–2) is a risk factor for HIV
infection.
- The detection of class IgG HSV antibodies may be used to determine the immune status of the patient using only a single serum sample or to support diagnosis of HSV primo infection through analysis of paired sera
collected 1-2 weeks apart. The detection of IgM antibodies serves as an evidence of primary active infection. However, low levels of IgM can also be detected upon virus reactivation in a latently infected host.
Serum IgA antibodies to HSV also reflects active infection, either primo infection or reactivation.
Overview on HSV assay kits
ELISA-VIDITEST  RUO |
| Order # |
Product |
Method |
Evaluation |
No. of tests |
Sample |
Sensitivity/ Specificity |
| ODZ-169 |
anti-HSV1+2 IgG |
ELISA |
semiquant. |
96 |
serum |
98.8% / 97% |
| ODZ-234 |
anti-HSV1+2 IgM |
ELISA |
semiquant. |
96 |
serum |
96.3% / 100% |
| LIA-VIDITEST RUO |
| ODZ-059 |
anti-HSV |
IFA |
semiquant. |
10x8 |
serum |
- |
ORDER INFORMATION
- For shipping and storage information please click on Order#.
| Order# |
Description |
Amount |
Price |
Data Sheet |
| ODZ-169 |
anti-HSV1+2 IgG |
96 wells |
144,00 |
PDF |
| ODZ-234 |
anti-HSV1+2 IgM |
96 wells |
144,00 |
PDF |
| ODZ-059 |
anti-HSV |
80 wells |
129,80 |
PDF |
- All prices are in EURO excl. VAT and shipping. Only available in selected countries.
Copyright
Distributed for 
